Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
March 22, 2018
Reata Announces Positive Top-Line Data for Treatment of PH-ILD With Bardoxolone Methyl From the Phase 2 Lariat Trial
IRVING, Texas, March 22, 2018 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (RETA) (Reata or Company), a clinical-stage biopharmaceutical company, today announced positive top-line data from ...
March 22, 2018
Zealand Pharma convenes its Annual General Meeting 2018
Copenhagen, March 22, 2018 - Zealand Pharma A/S ("Zealand") convenes the Company`s ordinary Annual General Meeting to be held on Thursday April 19, 2018 at 3.00 ...
March 22, 2018
Auris Medical Provides Business Update and Reports Fourth Quarter and Full Year 2017 Financial Results
Zug, Switzerland, March 22, 2018 - Auris Medical Holding AG (EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in ...
March 21, 2018
EDAP TMS SA : EDAP Announces CIGNA as First Major U.S. Private Health Insurer to Cover HIFU for Prostate Procedure
Lyon, France, Austin, TX -- March 21, 2018 - EDAP TMS SA (EDAP) today announced that CIGNA became the first major U.S. private health insurance ...
March 21, 2018
Checkpoint Therapeutics Initiates Dose Expansion Portion of Phase 1 Trial of Anti-PD-L1 Antibody CK-301
NEW YORK, March 21, 2018 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (CKPT), a clinical-stage, immuno-oncology biopharmaceutical company focused on the acquisition, development and commercialization ...
March 21, 2018
Eiger BioPharmaceuticals Announces Positive Guidance Following FDA Meeting on Hepatitis Delta Virus Registration Program
PALO ALTO, Calif., March 21, 2018 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (EIGR), focused on the development and commercialization of targeted therapies for rare diseases, announced today ...
March 21, 2018
Albireo to Present at 17th Annual Needham & Company Healthcare Conference
BOSTON, March 21, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced ...
March 21, 2018
BrainStorm Appoints Two Leading Thought Leaders in the Fields of Neuroscience and Regenerative Medicine to its Scientific Advisory Board
HACKENSACK, N.J. and PETACH TIKVAH, Israel, March 21, 2018 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (BCLI), a leading developer of adult stem cell therapies for neurodegenerative ...
March 21, 2018
Lipocine to Present at the 17th Annual Needham Healthcare Conference
SALT LAKE CITY, March 21, 2018 /PRNewswire/ -- Lipocine Inc. (LPCN), a specialty pharmaceutical company, announced today that Dr. Mahesh Patel, Chairman, President and CEO, will ...
March 21, 2018
Achaogen Announces Date of FDA Advisory Committee Meeting for Plazomicin
SOUTH SAN FRANCISCO, Calif., March 21, 2018 (GLOBE NEWSWIRE) -- Achaogen, Inc. (AKAO), a late-stage biopharmaceutical company developing innovative antibacterials addressing multi-drug resistant (MDR) gram-negative ...
March 21, 2018
Caelum Biosciences Announces Clinical Data on CAEL-101 in AL Amyloidosis Selected for Oral Presentation at 16th International Symposium on Amyloidosis
NEW YORK, March 21, 2018 (GLOBE NEWSWIRE) -- Caelum Biosciences, Inc. (“Caelum”), a Fortress Biotech, Inc. (FBIO) Company developing treatments for rare and life-threatening diseases, ...
March 20, 2018
AC Immune reports full-year 2017 financial results - successful first year as a public company
Lausanne, Switzerland, March 20, 2018 - AC Immune SA (ACIU), a Swiss-based, clinical stage biopharmaceutical company with a broad pipeline focused on neurodegenerative diseases, today ...
March 20, 2018
DURECT Announces FDA Advisory Committee Meeting for REMOXY® ER
CUPERTINO, Calif., March 20, 2018 /PRNewswire/ -- DURECT Corporation (DRRX) today announced that its licensee, Pain Therapeutics (PTIE), reported yesterday that the U.S. Food and Drug ...
March 20, 2018
Aeglea BioTherapeutics to Present at 17th Annual Needham Healthcare Conference
AUSTIN, Texas, March 20, 2018 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (AGLE), a clinical-stage biotechnology company that designs and develops innovative human enzyme therapeutics for ...
March 20, 2018
Rockwell Medical Announces Triferic Presentations at the 2018 Asia Pacific Congress of Nephrology
WIXOM, Mich., March 20, 2018 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (RMTI), announced today that four Triferic abstracts have been selected for presentation at the ...
March 20, 2018
Zealand Pharma's first Phase 3 trial with dasiglucagon for treatment of severe hypoglycemia successfully meets its primary objective
Copenhagen, March 20, 2018 - Zealand Pharma A/S ("Zealand") announces that the primary and key secondary objectives of the first multinational Phase 3 clinical trial of ...
March 20, 2018
BIOPHYTIS files for Orphan Drug Designation for Sarconeos in Duchenne Muscular Dystrophy (DMD)
PARIS, March 20, 2018 (GLOBE NEWSWIRE) --  BIOPHYTIS (Euronext Growth Paris:ALBPS), a biotechnology company specializing in the development of drug candidates to treat age-related degenerative diseases, ...
March 20, 2018
Arena Pharmaceuticals Announces Proposed Public Offering of Common Stock
SAN DIEGO, March 20, 2018 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (ARNA) today announced that it intends to offer and sell, subject to market and other conditions, ...
March 20, 2018
Altimmune to Announce Year End 2017 Financial Results on March 29
GAITHERSBURG, Md., March 20, 2018 (GLOBE NEWSWIRE) -- Altimmune, Inc. (ALT), a clinical-stage immunotherapeutics company, today announced that it will announce financial results for the ...
March 20, 2018
Prothena Announces Global Neuroscience Research & Development Collaboration with Celgene for Novel Therapies for Patients with Neurodegenerative Diseases
DUBLIN, Ireland, March 20, 2018 (GLOBE NEWSWIRE) -- Prothena Corporation plc (PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of ...
Page 97 of 158